drugset / Trial / NCT02397538

Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects

NCT02397538

RandomizedCrossoverOpen-label

Summary

An Open-label, Fixed-sequence, Crossover Study to Evaluate the Pharmacokinetic Interaction and Safety after multiple oral doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects.

Timeline

Start
2015-02
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified Oral
Subject Fimasartan Small molecule Oral
Subject Rosuvastatin Small molecule Oral

Indications